Quantcast

Latest Valve replacement Stories

2014-09-30 23:04:54

Icahn School of Medicine at Mount Sinai research findings show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve replacement with bioprosthetic valves compared with mechanical valves. New York, NY (PRWEB) September 30, 2014 New Icahn School of Medicine at Mount Sinai research findings published in the October 1 issue of JAMA show there was no significant difference in 15-year survival or stroke rates in...

2014-09-29 12:30:22

JENA, Germany, September 29, 2014 /PRNewswire/ -- Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European CE Mark approval for its dedicated Paravalvular Leak Closure Device, (PLD). The implant is the world's first, specifically designed device indicated for the minimally invasive closure of leaks occurring around artificial aortic and mitral valves. Tor Peters, CEO of the Occlutech Group, commented:...

2014-09-24 08:27:29

CHICAGO, September 24, 2014 /PRNewswire/ -- New valves may grow with patients and may have lower rejection rates Researchers have found a way to take a pediatric patient's skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary valve. A proof of concept study published in the September 2014 issue of The Annals of Thoracic Surgery provides more detail on this scientific...

2014-09-09 12:29:07

STASIS Clinical Study Begins in Europe NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ -- Micro Interventional Devices, Inc. (MID) reports the first successful clinical case using its Permaseal Cardiac Access and Closure technology. This new technology simplifies minimally invasive aortic valve replacement procedures. The patient is the first to be enrolled in the Secure Transapical Access and Closure Study (STASIS) being conducted in Europe. The first STASIS case was performed by Dr....

2014-08-27 16:25:51

AUSTIN, Texas, Aug. 27, 2014 /PRNewswire/ -- On Aug. 26, 2014, physicians at Heart Hospital of Austin became the first in Texas to implant the new Portico(TM) Re-sheathable Transcatheter Aortic Valve System--an innovative, repositionable aortic heart valve and delivery system. Heart Hospital of Austin is part of the PORTICO trial, a nationwide clinical study to examine the effectiveness of the new heart valve. The Portico valve was used during a catheter-based valve replacement...

heart
2014-08-14 02:00:48

DETROIT, Aug. 13, 2014 /PRNewswire/ -- For the first time in the United States, doctors at Henry Ford Hospital used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one - and placed it just outside the heart. Due to prior medical procedures, the metro Detroit woman was not a candidate for traditional open heart surgery to replace her failing tricuspid valve. One major U.S. medical center turned her down for treatment. Doctors at another said her...

2014-04-23 16:31:16

LONDON, April 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons' Confidence and Proficiency to Drive TAVR Procedure...

2014-04-09 16:26:11

ROSEVILLE, Minn., April 9, 2014 /PRNewswire/ -- Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company developing technologies for transcatheter mitral valve replacement, announced today that it has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendyne's novel Transcatheter Mitral Valve Implant to treat...

2014-03-31 13:26:39

Among patients undergoing aortic valve replacement using a catheter tube, a comparison of two types of heart valve technologies, balloon-expandable or self-expandable valve systems, found a greater rate of device success with the balloon-expandable valve, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. Transcatheter aortic valve replacement (TAVR) has emerged as a new option for patients with severe...

2014-03-26 12:29:52

Transcatheter Aortic Valve Replacement Devices Will See Rapid Adoption, But Are Unlikely to Match Success Seen in US and Europe, According to Findings from Decision Resources Group BURLINGTON, Mass., March 26, 2014 /PRNewswire/ -- Decision Resources Group finds that the Latin American market for heart valve devices will approach $200 million by 2022, with rapid growth driven largely by favorable demographics and the rising adoption of transcatheter heart valve (THV) products, including...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related